Recombinant human erythropoietin promotes the acquisition of a malignant phenotype in head and neck squamous cell carcinoma cell lines in vitro

BACKGROUND: Recent studies indicate an increase in tumor progression and recurrence in head and neck squamous cell carcinomas (HNSCC) of cancer patients taking recombinant human erythropoietin (rhEpo) for anemia. This study was undertaken to investigate the potential role of rhEpo in invasion, proli...

Descripción completa

Detalles Bibliográficos
Autores principales: Abhold, Eric, Rahimy, Elham, Wang-Rodriguez, Jessica, Blair, Katherine J, Yu, Michael A, Brumund, Kevin T, Weisman, Robert A, Ongkeko, Weg M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3285115/
https://www.ncbi.nlm.nih.gov/pubmed/22188703
http://dx.doi.org/10.1186/1756-0500-4-553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3285115/
https://www.ncbi.nlm.nih.gov/pubmed/22188703
http://dx.doi.org/10.1186/1756-0500-4-553

Ejemplares similares